mAbs Upstream processing
Developing and manufacturing mAbs has moved away from a dependency on raw materials of animal origin. Our biochemical components and supplements are animal component–free to meet the needs of these applications.
Products and supply chain fully supporting mAbs upstream processing
Products offered for upstream processing for mAbs are designed to support cell growth and productivity while meeting the required quality and performance parameters. This allows for seamless transfer from process development to pilot scale, and to final commercial manufacturing.
As you scale up your process, our supply chain management system can easily address increased quantities of material in the quality you need for GMP requirements. Use Avantor's expertise, our high-quality raw materials and large volume fluid handling solutions, globally aligned quality systems and platform in monoclonal antibodies to custom manufacture your medium in liquid or dry formats for efficient transfer to your bioreactor.
Plan ahead, avoid delays
Don't risk your mAbs scale-up success.
Explore solutions for upstream processing of mAbs
Discover Avantor's fluid handling solutions and access literature, technical articles and videos.
Improve your production process with Avantor’s cGMP and cGDP-supported chemicals and excipients.
Learn how Avantor Services bioprocessing specialists can help optimize your upstream and downstream operations.
Avantor’s environmental control solutions provide customized support for exactly how your facility operates.
Product choices for discovery, product development & pre-clinical
- Cell Culture Media
- Cloning & Expression Systems
- Electroporation
- Gene Editing
- Selection Antibiotics
- Transfection Reagents
Product choices for scale-up & production
Related content
Failing to plan is planning to fail: the case for early use of cGMP raw materials
Ready to maximize production efficiency?
Our Bioprocessing Solutions team is here to help.